Clinical Data Clinical Trial Results 28.7% Average Weight Loss 68 weeks 58.6% Achieved 25%+ Loss of participants 445 Trial Participants Phase 3 Data from the Phase 3 TRIUMPH-4 trial of retatrutide, reported by Eli Lilly (topline, 2025)
Many patients who take Bydureon or Byetta lose as much as 30 pounds after 12 months of taking the medication
The role of inflammation in cancer of the esophagus
Avoid fast food, pre-packaged meals, and snacks high in sugar, saturated fat, and sodium
If you are breastfeeding, data on semaglutide transfer to breast milk is limited
Unlike many traditional peels that focus on one primary active ingredient, this peel combines several well studied components into a cohesive system that works across different layers of the skin